abstract |
The present invention provides a monoclonal antibody specific for interferon α subtype α8 (hereinafter IFN α8) and its mutant protein, providing a hybridoma capable of producing this antibody, and IFN by the antibody. Providing a method for detecting α8 and its mutant protein, providing a method for purifying IFN α8 and the mutant protein by this antibody, and IFN α8 containing the antibody as an active ingredient, It is a task to provide a therapeutic agent. Monoclonal antibody specific for IFN α8 and its mutant protein, hybridomas capable of producing this antibody, IFN α8 and its mutant protein detection method by immune response using this antibody, IFN α8 using this antibody or its The present invention provides a method for purifying a mutant protein and a therapeutic agent for various diseases in which IFN alpha 8 containing the antibody as an active ingredient is involved in development or deterioration. |